e-Article
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial
Document Type
Article
Author
Norton, Sam; Lempp, Heidi; Opena, Maria; Subesinghe, Sujith; Garrood, Toby; Menon, Bina; Ng, Nora; Douglas, Karen; Koutsianas, Christos; Cooles, Faye; Falahee, Marie; Echavez-Naguicnic, Irene; Bharadwaj, Anurag; Villaruel, Michael; Pande, Ira; Collins, David; Pegler, Suzannah; Raizada, Sabrina; Siebert, Stefan; Fragoulis, George; Guinto, Jesusa; Galloway, James; Rutherford, Andrew; Barnes, Theresa; Jeffrey, Helen; Patel, Yusuf; Batley, Michael; O'Reilly, Brendan; Venkatachalam, Srivinisan; Sheeran, Thomas; Gorman, Claire; Reynolds, Piero; Khan, Asad; Gullick, Nicola; Banerjee, Siwalik; Mankia, Kulveer; Jordan, Deepak; Rowlands, Jane; Starmans-Kool, Mirian; Taylor, James; Nandi, Pradip; Sahbudin, Ilfita; Maybury, Mark; Hider, Samantha; Barcroft, Ann; McNally, Jeremy; Kitchen, Jo; Nisar, Muhammad; Quick, Vanessa; Cope, Andrew P ; Jasenecova, Marianna; Vasconcelos, Joana C; Filer, Andrew; Raza, Karim; Qureshi, Sumera; D'Agostino, Maria Antonietta; McInnes, Iain B; Isaacs, John D; Pratt, Arthur G; Fisher, Benjamin A; Buckley, Christopher D; Emery, Paul; Ho, Pauline; Buch, Maya H; Ciurtin, Coziana; van Schaardenburg, Dirkjan; Huizinga, Thomas; Toes, René; Georgiou, Evangelos; Kelly, Joanna; Murphy, Caroline; Prevost, A Toby
Source
In The Lancet 2-8 March 2024 403(10429):838-849
Subject
Language
ISSN
0140-6736